The role of KDM4A‐mediated histone methylation on temozolomide resistance in glioma cells through the HUWE1/ROCK2 axis
出版年份 2023 全文链接
标题
The role of KDM4A‐mediated histone methylation on temozolomide resistance in glioma cells through the HUWE1/ROCK2 axis
作者
关键词
-
出版物
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2023-10-24
DOI
10.1002/kjm2.12768
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Mechanism of circHIPK3-miRNA-124-3p/miRNA-148b-3p-Mediated Inflammatory Responses and Cell Senescence in <b><i>Candida albicans</i></b>-Induced Septic Acute Kidney Injury
- (2022) Jing Han et al. GERONTOLOGY
- NcRNAs: Multi‑angle participation in the regulation of glioma chemotherapy resistance (Review)
- (2022) Zhaomu Zeng et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The giant E3 ligase HUWE1 is linked to tumorigenesis, spermatogenesis, intellectual disability, and inflammatory diseases
- (2022) Lu Qi et al. Frontiers in Cellular and Infection Microbiology
- The E3 ubiquitin ligase HUWE1 acts through the N‐Myc‐DLL1‐NOTCH1 signaling axis to suppress glioblastoma progression
- (2022) Ye Yuan et al. Cancer Communications
- Mechanistic insights into KDM4A driven genomic instability
- (2021) Nicolas L. Young et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- The emerging role of KDM5A in human cancer
- (2021) Guan-Jun Yang et al. Journal of Hematology & Oncology
- Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Gliomas
- (2021) Zheng Zhao et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- KDM4A-mediated histone demethylation of SLC7A11 inhibits cell ferroptosis in osteosarcoma
- (2021) Meng Chen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Targeting KDM4A epigenetically activates tumor-cell-intrinsic immunity by inducing DNA replication stress
- (2021) Wuchang Zhang et al. MOLECULAR CELL
- Unravelling KDM4 histone demethylase inhibitors for cancer therapy
- (2021) Stephin Baby et al. DRUG DISCOVERY TODAY
- Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance.
- (2021) Manendra Singh Tomar et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Targeting KDM4A-AS1 represses AR/AR-Vs deubiquitination and enhances enzalutamide response in CRPC
- (2021) Boya Zhang et al. ONCOGENE
- Targeting ROCK signaling in health, malignant and non-malignant diseases
- (2020) Roya Shahbazi et al. IMMUNOLOGY LETTERS
- The structure and regulation of the E3 ubiquitin ligase HUWE1 and its biological functions in cancer
- (2020) Xiaofeng Gong et al. INVESTIGATIONAL NEW DRUGS
- Impact of RhoA overexpression on clinical outcomes in cervical squamous cell carcinoma treated with concurrent chemoradiotherapy
- (2020) Keiichi Tanaka et al. JOURNAL OF RADIATION RESEARCH
- O6-Methylguanine-DNA Methyltransferase (MGMT): Challenges and New Opportunities in Glioma Chemotherapy
- (2020) Wei Yu et al. Frontiers in Oncology
- LncRNA MAGI2-AS3 is downregulated in the distant recurrence of hepatocellular carcinoma after surgical resection and affects migration and invasion via ROCK2
- (2020) Gang Fang et al. Annals of Hepatology
- Inhibition of noncanonical Wnt pathway overcomes enzalutamide resistance in castration‐resistant prostate cancer
- (2019) Xiaoliang Chen et al. PROSTATE
- CDKL5 promotes proliferation, migration, and chemotherapeutic drug resistance of glioma cells via activation of the PI3K/AKT signaling pathway
- (2019) Zhenfu Jiang et al. FEBS Open Bio
- Fasudil increases temozolomide sensitivity and suppresses temozolomide-resistant glioma growth via inhibiting ROCK2/ABCG2
- (2018) Xin Zhang et al. Cell Death & Disease
- Disulfiram, a Re-positioned Aldehyde Dehydrogenase Inhibitor, Enhances Radiosensitivity of Human Glioblastoma Cells In Vitro
- (2018) Hyeon Kang Koh et al. Cancer Research and Treatment
- Downregulation of KDM4A Suppresses the Survival of Glioma Cells by Promoting Autophagy
- (2016) Bo Wang et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Rho Kinase (ROCK) Inhibitors and Their Therapeutic Potential
- (2015) Yangbo Feng et al. JOURNAL OF MEDICINAL CHEMISTRY
- The epidemiology of glioma in adults: a "state of the science" review
- (2014) Q. T. Ostrom et al. NEURO-ONCOLOGY
- Downregulation of ROCK2 through Nanocomplex Sensitizes the Cytotoxic Effect of Temozolomide in U251 Glioma Cells
- (2014) Xiaojun Wen et al. PLoS One
- Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas
- (2013) Adam M. Fontebasso et al. ACTA NEUROPATHOLOGICA
- Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis
- (2013) F Peng et al. BRITISH JOURNAL OF CANCER
- A Network of Substrates of the E3 Ubiquitin Ligases MDM2 and HUWE1 Control Apoptosis Independently of p53
- (2013) M. Kurokawa et al. Science Signaling
- Antitumor Activity of NVP-BKM120--A Selective Pan Class I PI3 Kinase Inhibitor Showed Differential Forms of Cell Death Based on p53 Status of Glioma Cells
- (2011) D. Koul et al. CLINICAL CANCER RESEARCH
- Alkylpurine–DNA–N-glycosylase confers resistance to temozolomide in xenograft models of glioblastoma multiforme and is associated with poor survival in patients
- (2011) Sameer Agnihotri et al. JOURNAL OF CLINICAL INVESTIGATION
- Effect of aberrant p53 function on temozolomide sensitivity of glioma cell lines and brain tumor initiating cells from glioblastoma
- (2010) Michael D. Blough et al. JOURNAL OF NEURO-ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started